List of bibliographic references
Number of relevant bibliographic references: 17.
| Ident. | Authors (with country if any) | Title |
|---|
| 000034 (2020) |
Angelika Batta ; Bhupinder Singh Kalra ; Raj Khirasaria | Trends in FDA drug approvals over last 2 decades: An observational study |
| 000059 (2020) |
Banafsheh Mosharmovahed [Iran] ; Yousef Fatahi [Iran] ; Bahareh Mohebbi [Iran] ; Sohrab Ali Ghorbanian [Iran] ; Sara Assadiasl [Iran] | Tocilizumab in transplantation. |
| 000160 (2020) |
Anna A. Starshinova [Russie] ; Anna M. Malkova [Russie] ; Natalia Y. Basantsova [Russie] ; Yulia S. Zinchenko [Russie] ; Igor V. Kudryavtsev [Russie] ; Gennadiy A. Ershov [Russie] ; Lidia A. Soprun [Russie] ; Vera A. Mayevskaya [Russie] ; Leonid P. Churilov [Russie] ; Piotr K. Yablonskiy [Russie] | Sarcoidosis as an Autoimmune Disease |
| 000193 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000214 (2020) |
Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse] | Progression of fibrosing interstitial lung disease |
| 000299 (2020) |
Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis] | Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties |
| 000345 (2020) |
| Immune-Related Adverse Events: Pneumonitis |
| 000347 (2020) |
Julia Shekunov [États-Unis] ; Caren J. Blacker [États-Unis] ; Jennifer L. Vande Voort [États-Unis] ; Jan-Mendelt Tillema [États-Unis] ; Paul E. Croarkin [États-Unis] ; Magdalena Romanowicz [États-Unis] | Immune mediated pediatric encephalitis – need for comprehensive evaluation and consensus guidelines |
| 000350 (2020) |
Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel Wolff | IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis |
| 000376 (2020) |
Theodore A. Henderson [États-Unis] ; Muriel J. Van Lierop [États-Unis, Canada] ; Mary Mclean [États-Unis, Canada] ; John Michael Uszler [États-Unis] ; John F. Thornton [États-Unis, Canada] ; Yin-Hui Siow [États-Unis, Canada] ; Dan G. Pavel [États-Unis] ; Joe Cardaci [États-Unis, Australie] ; Phil Cohen [États-Unis, Canada] | Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know |
| 000390 (2020) |
Patricia Richi [Espagne] ; Oriol Alonso [Espagne] ; María Dolores Martín [Espagne] ; Laura González-Hombrado [Espagne] ; Teresa Navío [Espagne] ; Marina Salido [Espagne] ; Jesús Llorente [Espagne] ; Cristina Andreu-Vázquez [Espagne] ; Cristina García-Fernández [Espagne] ; Ana Jiménez-Diaz [Espagne] ; Leticia Lojo [Espagne] ; Laura Cebrián [Espagne] ; Israel Thuissard-Vasallo [Espagne] ; María José Martínez De Aramayona [Espagne] ; Tatiana Cobo [Espagne] ; Marta García-Castro [Espagne] ; Patricia Castro [Espagne] ; M Nica Fernández-Castro [Espagne] ; Scar Illera [Espagne] ; Martina Steiner [Espagne] ; Santiago Mu Oz-Fernández [Espagne] | Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study. |
| 000391 (2020) |
Slobodan M. Jankovic [Serbie] ; Izet Masic [Bosnie-Herzégovine] | Evaluation of Preclinical and Clinical Studies Published in Medical Journals of Bosnia and Herzegovina: Methodology Issues |
| 000424 (2020) |
Salah Ghabri [France] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Franck Maunoury [France] ; J Jaime Caro [États-Unis] | Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France. |
| 000425 (2020) |
Gary H. Lyman [États-Unis] ; Andy Nguyen [États-Unis] ; Sophie Snyder [États-Unis] ; Matthew Gitlin [États-Unis] ; Karen C. Chung [États-Unis] | Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma |
| 000445 (2020) |
A. Charlotte M. T. De Wolf ; Carla A. Herberts ; Marcel H. N. Hoefnagel | Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised |
| 000455 (2020) |
Hao Wang [République populaire de Chine] ; Zheng Xiao [République populaire de Chine] | Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis |
| 000552 (2020) |
Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] | COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "evaluation"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i \
-Sk "evaluation" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= evaluation
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
